Literature DB >> 8625760

Effects of somatostatin on luminal transit and absorption of nutrients in the proximal gut of minipigs.

J Eisenbraun1, H J Ehrlein.   

Abstract

A discrepancy exists on the effects of somatostatin on the absorption of nutrients: in humans, absorption was found to be reduced, whereas in rats no effects were observed. However, intestinal absorption might be influenced by the transit rate of contents. This was not considered in previous studies. Therefore, we investigated simultaneously the effects of somatostatin on the absorption of nutrients and on luminal transit. In five minipigs (44-62 kg), a 150-cm segment of the proximal jejunum was temporarily isolated by two cannulas and perfused with an oligomer diet (60% carbohydrate, 18% protein, and 22% fat). The perfusion rate was 2 kcal/min. Flow rate and mean transit time were determined by markers (Cr-EDTA and Cu-EDTA). Somatostatin was infused intravenously at rates of 0.5, 1.25, 2.5, and 5 micrograms/kg/hr. In control experiments saline was administered intravenously. Somatostatin dose-dependently diminished flow rate of luminal contents and increased the transit time. At the largest dose of somatostatin (5 micrograms/kg/hr) flow rate was reduced by 50% compared with control infusion of saline (1.0 +/- 0.4 vs 2.0 +/- 0.05 ml/min, P < 0.05), and transit time was increased 3.6-fold (39.8 +/- 4.7 vs 11.2 +/- 4.9 min; P < 0.05). Somatostatin also dose-dependently enhanced the absorption of nutrients and energy. However, the increase in absorption was small compared with the effects on flow rate and transit time. At the largest dose (5 micrograms/kg/hr) absorption of energy, carbohydrate, protein, and fat was enhanced only by 9.7%, 7.0%, 5.2%, and 15.3%, respectively (49.9 vs 40.2%, 50.9 vs 43.9%, 67.3 vs 62.1%, and 30.1 vs 14.8% during saline infusion; P < 0.05). Results indicate that the major effects of somatostatin consist in a marked reduction of flow rate and a delay of luminal transit. The small increase in absorption was caused by the delay in transit and the prolonged contact of the nutrients with the mucosa. Therefore, in absorption studies, effects on transit need to be considered.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8625760     DOI: 10.1007/bf02091528

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  Thermogenesis and fructose metabolism in humans.

Authors:  J M Schwarz; K J Acheson; L Tappy; V Piolino; M J Müller; J P Felber; E Jéquier
Journal:  Am J Physiol       Date:  1992-05

2.  Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome.

Authors:  W O Richards; R Geer; T M O'Dorisio; T Robarts; K L Parish; D Rice; G Woltering; N N Abumrad
Journal:  J Surg Res       Date:  1990-12       Impact factor: 2.192

3.  Jejunal efflux in short bowel syndrome.

Authors:  J M Nightingale; J E Lennard-Jones; E R Walker; M J Farthing
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

4.  Effects of enteral feedback inhibition on motility, luminal flow, and absorption of nutrients in proximal gut of minipigs.

Authors:  A Huge; E Weber; H J Ehrlein
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

5.  Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes.

Authors:  G J Krejs; R Browne; P Raskin
Journal:  Gastroenterology       Date:  1980-01       Impact factor: 22.682

6.  The effects of somatostatin and selected analogs on lipid absorption in animals.

Authors:  E E Slater; H M Katzen; R F Nutt; R Saperstein; S L Steelman
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

7.  Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome.

Authors:  K Ladefoged; K C Christensen; J Hegnhøj; S Jarnum
Journal:  Gut       Date:  1989-07       Impact factor: 23.059

8.  Long acting somatostatin analogue in dumping syndrome.

Authors:  Z Tulassay; T Tulassay; R Gupta; G Cierny
Journal:  Br J Surg       Date:  1989-12       Impact factor: 6.939

9.  Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus.

Authors:  J Wahren
Journal:  Lancet       Date:  1976-12-04       Impact factor: 79.321

Review 10.  Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.

Authors:  P E Battershill; S P Clissold
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

View more
  2 in total

1.  Intestinal electric stimulation decreases fat absorption in rats: therapeutic potential for obesity.

Authors:  Ying Sun; Jiande Chen
Journal:  Obes Res       Date:  2004-08

2.  Effect of explosive noise on gastrointestinal transit and plasma levels of polypeptide hormones.

Authors:  Zhen-Bin Mu; Yu-Xin Huang; Bao-Min Zhao; Zhen-Xiong Liu; Bing-Hua Zhang; Qing-Li Wang
Journal:  World J Gastroenterol       Date:  2006-04-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.